Other substances

Rifapentine

An antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Rifapentine on PubChem

Marketed as

PRIFTIN

 

Structure image - Rifapentine

C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C

Supporting references

Link Tested on Impact factor Notes Publication date
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
RdRpol Small molecule In silico 		in silico 5.16

Predicted to bind the SARS-CoV-2 RNA-dependent RNA polymerase.

 Sep/17/2020

AI-suggested references

Link Publication date
Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Nov/20/2021
Export (.csv)